91 related articles for article (PubMed ID: 6745761)
1. [Serum copper levels in Hodgkin's disease].
Cohen Y; Epelboim R; Haim N; Zinder O
Harefuah; 1984 Mar; 106(6):252-4. PubMed ID: 6745761
[No Abstract] [Full Text] [Related]
2. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
3. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
Jelliffe AM
Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
[No Abstract] [Full Text] [Related]
4. Interpreting serum copper levels in Hodgkin's disease.
Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
[No Abstract] [Full Text] [Related]
5. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
[No Abstract] [Full Text] [Related]
6. [Plasma copper and zinc levels in Hodgkin's disease].
Cappelaere P; Sulman C; Chechan C; Gosselin-Dulaquais P
Lille Med; 1975 Dec; 20(10):904-13. PubMed ID: 1207358
[No Abstract] [Full Text] [Related]
7. Comparison of electron paramagnetic resonance and atomic absorption serum copper measurements in human normal control and cancer patients.
Kleinhans FW; Kline SC; Dugan WM; Williams JG
Cancer Res; 1983 Jul; 43(7):3447-50. PubMed ID: 6303584
[TBL] [Abstract][Full Text] [Related]
8. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
[No Abstract] [Full Text] [Related]
9. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
Cepelja Z; Grgić Z; Markinković M; Ivanov D
Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
[No Abstract] [Full Text] [Related]
10. [Serum iron and serum copper in patients with lymphogranulomatosis].
Anders O; Klemm HJ; Bendel L; Konrad H
Z Gesamte Inn Med; 1984 Apr; 39(8):169-72. PubMed ID: 6730594
[TBL] [Abstract][Full Text] [Related]
11. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
RECHENBERGER J
Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
[No Abstract] [Full Text] [Related]
12. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
[No Abstract] [Full Text] [Related]
13. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
[TBL] [Abstract][Full Text] [Related]
14. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the blood copper in Hodgkin's disease.
PAGLIARDI E; GIANGRANDI E
Acta Haematol; 1960 Oct; 24():201-12. PubMed ID: 13732060
[No Abstract] [Full Text] [Related]
16. Plasma zinc levels in Hodgkin's disease. Evaluation of 37 cases.
Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
Haematologica; 1978 Apr; 63(2):143-55. PubMed ID: 98399
[No Abstract] [Full Text] [Related]
17. Prolonged observations on variations in the serum copper in Hodgkin's disease.
Warren RL; Jelliffe AM; Watson JV; Hobbs CB
Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
[No Abstract] [Full Text] [Related]
18. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
[No Abstract] [Full Text] [Related]
19. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
20. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
